Grant: CIHR Fellowship
McMaster University
$135,000.00
Impact of cannabis smoke exposure on the respiratory mucosal response to viral infection as well as host mortality and morbidity
FY 2021-22
Summary
The United Nations World Drug Report estimates that over 180 million individuals use cannabis with 90% of users preferring smoking as a delivery route. Cannabis smokers have a higher incidence of coughing and chronic bronchitis relative to non-smokers, symptoms that are shared with tobacco smokers. Respiratory viral infections are more common in tobacco smokers, with greater influenza-related morbidity and mortality occurring in this population. Whether cannabis smokers are similarly susceptible to influenza infections remains unclear. This is important as influenza results in 250,000-500,000 global deaths annually. Our goal is to determine the impact of cannabis smoke on antiviral immunity and the mortality associated with viral infection. Using diverse cannabis strains available under a Health Canada approved license, we plan to expose human lung cells and animal models to cannabis smoke and assess their response to influenza A infection. Our approach will provide modern evidence to inform health policy, by defining the impact of cannabis smoke on antiviral responses as well as mortality risks associated with influenza A infection.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
454884
Name
Milad Nadia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Health Research Training B - HP
Projecttitle
Impact of cannabis smoke exposure on the respiratory mucosal response to viral infection as well as host mortality and morbidity
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cannabis; Immunology; Influenza A; Mouse Models; Smoke Exposure; Viral Infection
Abstract
The United Nations World Drug Report estimates that over 180 million individuals use cannabis with 90% of users preferring smoking as a delivery route. Cannabis smokers have a higher incidence of coughing and chronic bronchitis relative to non-smokers, symptoms that are shared with tobacco smokers. Respiratory viral infections are more common in tobacco smokers, with greater influenza-related morbidity and mortality occurring in this population. Whether cannabis smokers are similarly susceptible to influenza infections remains unclear. This is important as influenza results in 250,000-500,000 global deaths annually. Our goal is to determine the impact of cannabis smoke on antiviral immunity and the mortality associated with viral infection. Using diverse cannabis strains available under a Health Canada approved license, we plan to expose human lung cells and animal models to cannabis smoke and assess their response to influenza A infection. Our approach will provide modern evidence to inform health policy, by defining the impact of cannabis smoke on antiviral responses as well as mortality risks associated with influenza A infection.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Milad, Nadia
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~